Obstetrics/Gynecology(Women's Health)

Micronutrient Supplementation Before and During 1st Pregnancy to Improve Birth Outcomes (JiVitA-5)

Conditions:   Birth Weight;   Miscarriage;   Small-for-gestational Age;   Preterm Birth
Interventions:   Dietary Supplement: Multiple micronutrient supplement;   Drug: Placebo Oral Tablet
Sponsors:   Johns Hopkins Bloomberg School of Public Health;   JiVitA Project, Gaibandha, Bangladesh
Recruiting
ClinicalTrials.gov: Womens_Health | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 30, 2019Comments OffBefore | Birth | During | Improve | JiVitA5 | Micronutrient | Outcomes | Pregnancy | Supplementation
Leveraging the Emergency Department to Engage African American Women in HIV Pre-Exposure Prophylaxis

Condition:   HIV Infections
Interventions:   Behavioral: iPrEP;   Behavioral: Usual Care
Sponsor:   The University of Texas Health Science Center, Houston
Not yet recruiting
ClinicalTrials.gov: Womens_Health | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 29, 2019Comments OffAfrican | American | Department | Emergency | Engage | Leveraging | PreExposure | Prophylaxis | Women
Providing Expanded Continuous Labor Support to Pregnant Women in New Mexico With Substance Use Disorders

Conditions:   Pregnancy Related;   Substance Use Disorders
Intervention:   Other: Continuous Labor Support
Sponsor:   University of New Mexico
Recruiting
ClinicalTrials.gov: Womens_Health | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 28, 2019Comments OffContinuous | Disorders | Expanded | Labor | Mexico | Pregnant | Providing | Substance | Support | Women
A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Condition:   Uterine Fibroids
Interventions:   Drug: Elagolix;   Drug: Placebo
Sponsor:   AbbVie
Recruiting
ClinicalTrials.gov: Gynecology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 27, 2019Comments OffAssociated | Bleeding | Efficacy | Elagolix | Evaluate | Fibroids | Heavy | Management | Menstrual | Premenopausal | Safety | Study | Uterine | Women
Technology-Based Intervention for Reducing Sexually Transmitted Infections and Substance Use During Pregnancy

Conditions:   Sexually Transmitted Infection;   Alcohol Use Complicating the Puerperium;   Alcohol Use Complicating Pregnancy, Unspecified Trimester;   Drug Use
Interventions:   Behavioral: Health Check-up for Expectant Moms;   Behavioral: Information-matched control
Sponsors:   University of Michigan;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting
ClinicalTrials.gov: Womens_Health | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 26, 2019Comments OffDuring | Infections | Intervention | Pregnancy | Reducing | Sexually | Substance | TechnologyBased | Transmitted
Whole Exome Sequencing and Whole Genome Sequencing for Non-immune Fetal/Neonatal Hydrops

Conditions:   Non-immune Fetal Hydrops;   Non-Immune Hydrops in Neonate;   Genetic Disorders
Interventions:   Diagnostic Test: Whole Exome Sequencing;   Diagnostic Test: Whole Genome Sequencing
Sponsor:   Thomas Jefferson University
Recruiting
ClinicalTrials.gov: Obstetrics | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 25, 2019Comments OffExome | Fetal/Neonatal | Genome | Hydrops | Nonimmune | Sequencing | Whole
Role of ASpirin in Placental and Maternal Endothelial Cell Regulation IN Pre-eclampsia

Condition:   Pre-Eclampsia
Interventions:   Drug: Acetylsalicylic Acid 81 mg;   Drug: Acetylsalicylic Acid 162 mg;   Other: Control
Sponsor:   John O’Brien, MD
Not yet recruiting
ClinicalTrials.gov: Gynecology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 23, 2019Comments OffAspirin | Cell | Endothelial | Maternal | Placental | Preeclampsia | Regulation | Role
Tenofovir Alafenamide in Preventing Liver Complications in Participants With Current or Past Hepatitis B Virus Who Are Receiving Anti-Cancer Therapy for Solid Tumors

Conditions:   Hepatitis B Virus Positive;   Malignant Solid Neoplasm
Interventions:   Other: Best Practice;   Other: Laboratory Biomarker Analysis;   Drug: Tenofovir Alafenamide
Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
Recruiting
ClinicalTrials.gov: Gynecology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 22, 2019Comments OffAlafenamide | AntiCancer | Complications | Current | Hepatitis | Liver | Participants | Past | Preventing | Receiving | Solid | Tenofovir | Therapy | Tumors | Virus
the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer

Conditions:   Endometrial Cancer;   Overweight
Intervention:   Behavioral: Profile by Sanford weight management plan
Sponsor:   Sanford Health
Recruiting
ClinicalTrials.gov: Gynecology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 21, 2019Comments OffCancer | Completed | Effectiveness | Endometrial | Management | Patients | Program | Treatment | Weight